CUSIP: 171126204 | NYSE | Healthcare · Biotechnology | Micro Cap | 32 institutional holders
5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.
| Holder | Shares | % of Class | Change | Event Date | vs 13F |
|---|---|---|---|---|---|
| 13D/ALigand Pharmaceuticals Incorporated | 5,189,177 | 49.9% | Unchanged | Oct 30, 2026 | No 13F filer matched |
| Style | Turnover | Location | Filed | ||||
|---|---|---|---|---|---|---|---|
| 256,012 | $5.4M | 0.5% | GARP | Very High | Baltimore, MD | 2026-11-02 | |
| 2,360 | $49.4K | 0.0% | Growth | Medium | Shanghai, France | 2026-10-28 | |
| 40 | $840 | 0.0% | Index | Low | San Francisco, CA | 2026-10-08 | |
| 5 | $105 | 0.0% | Index | Low | San Francisco, CA | 2026-11-03 |